Your browser doesn't support javascript.
loading
Gemcitabine-based regimen for primary ovarian angiosarcoma with MYC amplification.
Yonezawa, I; Waki, M; Tamura, Y; Onoda, R; Narushima, M; Ishizuka, T; Tajima, S.
Affiliation
  • Yonezawa I; Obstetrics and Gynecology, Shizuoka Saiseikai General Hospital, Shizuoka, Japan.
  • Waki M; Cell Biology and Anatomy, Hamamatsu University School of Medicine, Shizuoka, Japan.
  • Tamura Y; Obstetrics and Gynecology, Shizuoka Saiseikai General Hospital, Shizuoka, Japan.
  • Onoda R; Obstetrics and Gynecology, Shizuoka Saiseikai General Hospital, Shizuoka, Japan.
  • Narushima M; Obstetrics and Gynecology, Shizuoka Saiseikai General Hospital, Shizuoka, Japan.
  • Ishizuka T; Obstetrics and Gynecology, Shizuoka Saiseikai General Hospital, Shizuoka, Japan.
  • Tajima S; Pathology, Shizuoka Saiseikai General Hospital, Shizuoka, Japan.
Curr Oncol ; 21(6): e782-9, 2014 Dec.
Article in En | MEDLINE | ID: mdl-25489268
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Curr Oncol Year: 2014 Type: Article Affiliation country: Japan
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Curr Oncol Year: 2014 Type: Article Affiliation country: Japan